Company intelligence / Profile preview

Perineologic

Cumberland, Maryland, United Statesperineologic.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company's flagship product, the PrecisionPoint® Transperineal Access System, received FDA clearance in 2016. It enables free-handed transperineal prostate biopsies that avoid the rectum entirely—improving safety by reducing infection risk and increasing diagnostic yield by allowing better access to anterior regions of the prostate where cancers are often missed with traditional transrectal approaches. Clinical studies have shown improved detection rates and patient outcomes compared to standard methods.

Therapeutic areas: Oncology
Modalities: Device (specifically, medical device for biopsy)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Perineologic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perineologic.

Explore the full profile